← Evidence map

ArticleGlycobiology2016

The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.

Sang W Hyun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27226251